跳至主要内容
临床试验/NCT06769035
NCT06769035进行中(未招募)不适用

Effect of a Food Supplement with Extracts of Cocoa, Amaranth Seed and Ginger in Overweight or Obese Patients in the Outpatient Clinic of the New Juan I. Menchaca Civil Hospital

University of Guadalajara1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年8月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40
试验地点
1
主要终点
Change from baseline in Insulin Resistance (IR) at 3 months

研究概览

简要总结

Clinical trial, randomized, double-blind, controlled with a placebo group, 40 patients between 18 and 60 years of age, with the presence of overweight, will be divided into parallel groups, group A cocoa, amaranth seed and ginger, group B cocoa, group C amaranth, group D placebo, with the objective of evaluating the effect of the nutritional supplement in overweight or obese patients on cytokines, insulin resistance and oxidative stress. The study consists of 4 visits: screening (-21 days), baseline (day 0), follow-up (week 6) and end of the study (12 weeks) and 2 follow-up calls (weeks 3 and 10). For 12 weeks they will take one sachet of the supplement containing cocoa, amaranth seed and ginger or placebo daily. Waist circumference, somatometric parameters, vital signs, nocturnal decrease in blood pressure, ankle arm index, cytokines, glucose, glycated hemoglobin, hs-CRP, lipid profile, insulin, antioxidant effect, blood cytometry, function tests will be evaluated. liver, urea, creatinine, uric acid and urine pregnancy test for women of childbearing age. A 24-hour reminder and frequency of consumption will be carried out to assess the diet at each of the visits and nutritional recommendations will be given. Adherence to treatment (Morisky-Green), adverse events and concomitant treatments will be verified throughout the study.

详细描述

Overweight and obesity are a public health problem with worldwide prevalence and play an important role in the emergence of chronic diseases. Overweight is characterized by low-grade chronic inflammation and is associated with an abnormal inflammatory response, oxidative stress and low sensitivity. to insulin. Inflammation of adipose tissue is initiated and sustained over time by dysfunctional adipocytes that secrete inflammatory adipokines; elevated proinflammatory stimuli directly affect insulin signaling in target tissues. Oxidative stress alters mitochondrial activity, modifies the concentration of inflammation levels associated with many adipocytes, promotes lipogenesis, stimulates the change of preadipocytes for mature adipocytes and regulates the energy balance in neurons that control appetite. It is also an important regulator. of insulin sensitivity.

The solution to the consequences of obesity and overweight, low-grade inflammation, oxidative stress and insulin sensitivity are based on pharmaceutical treatments and surgical processes, but changes in lifestyle are the cornerstone of treatment, however the patient's adherence to treatment is low and the results are long-term, for this reason some authors have dedicated themselves to looking for alternatives that complement changes in lifestyle and improve health status.

Polyphenols are bioactive compounds that have been shown to influence insulin resistance, oxidative stress and inflammation. There is extensive evidence from clinical studies and meta-analyses in overweight patients to support the effects of this study's supplement on waist circumference, weight, BMI, blood pressure, insulin sensitivity, markers of inflammation, and oxidative stress.

Cocoa has been positioned as a preventive phytopharmaceutical due to its polyphenolic compounds, mainly flavonols with anti-inflammatory and antioxidant effects, which can help prevent or delay the complications of DM2 by modulating insulin secretion.

Amaranth seed is a source of protein, calcium, iron, dietary fiber, vitamin E and D, with a high content of monounsaturated fats and polyunsaturated fatty acids such as squalene, which have been given anti-inflammatory and antioxidant properties, Mozak and collaborators in 2018 did a clinical trial with amaranth seed in overweight patients with favorable results in reducing fasting insulin and the HOMA-IR index.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Signed informed consent;
  • •Men or women;
  • •Age between 18 and 60 years;
  • •Waist circumference ≥ 88 cm in women or ≥ 94 cm in men;
  • •Plus one of the following criteria:
  • •BMI >25 kg/m2 and not > 30 kg/m2 in both genders or history of bariatric surgery > 6 months;
  • •Fasting serum glucose of 100-125 mg/dL or HbA1c of 5.7-6.4% or on pharmacological treatment with OAD for prediabetes;
  • •Insulin resistance by HOMA > 2.6 and insulin sensitivity by QUICKI <0.34;F.
  • •Negative pregnancy test.

排除标准

  • •On pharmacological treatment or diet for weight control;
  • •Routine use of antioxidants in the last 3 months;
  • •BMI ≥ 30 kg/m2 or recent bariatric surgery (< 6 months);
  • •LDL cholesterol > 160 mg/dL or total cholesterol > 200 mg/dL, and no treatment for dyslipidemia;
  • •Major micro or macrovascular complications due to severe metabolic disease (history of acute coronary syndrome, cerebrovascular disease, peripheral arterial insufficiency or aortic aneurysm);
  • •Pregnancy or breastfeeding;
  • •Refusal to use an effective contraceptive method for the duration of the study;
  • •Hypersensitivity to any of the components of the formula or phenylketonurics;
  • •Endocrinological or rheumatic diseases;
  • •Patient with recent initiation of vigorous physical exercise or exercise routine for weight loss and/or;
  • •Liver or kidney failure by clinical and/or laboratory criteria.

研究组 & 干预措施

Food supplement: cocoa, amaranth seed and ginger

Active Comparator

Group A:

20g Cocoa, 10g amaranth seed and 1g ginger once a day for 12 weeks

干预措施: Cocoa, amaranth seed and ginger (Dietary Supplement)

Food supplement: amaranth

Active Comparator

Group C:

10g Amaranth seed once a day for 12 weeks

干预措施: Amaranth seed (Dietary Supplement)

Food supplement: placebo

Placebo Comparator

Group D:

Coloring and flavoring, one dose per day for 12 weeks

干预措施: Placebo (Dietary Supplement)

Food supplement: cocoa

Active Comparator

Group B:

20g Cocoa once a day for 12 weeks

干预措施: Cocoa (Dietary Supplement)

结局指标

主要结局

Change from baseline in Insulin Resistance (IR) at 3 months

时间窗: Change from baseline visit to final 3 months

Average baseline and final HOMA-IR index

Change from baseline in oxidative stress markers Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX)

时间窗: Change from baseline visit to final 3 months

Basal and final average of SOD, CAT and GPX

次要结局

  • Change in metabolic variables (Weight, kg) (Height, m) (Body Mass Index BMI)(Change from baseline visit to final 3-month period)
  • Change in metabolic variables (Waist Circumference WC, cm)(Change from baseline visit to final 3-month period)
  • Change in metabolic variables (% fat, % visceral fat)(Change from baseline visit to final 3-month period)
  • Change in metabolic variables (Muscle Mass MM, kg)(Change from baseline visit to final 3-month period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Luis Miguel Román Pintos

Doctor in pharmacology and internist. Professor at University of Guadalajara

University of Guadalajara

研究点 (1)

Loading locations...

相似试验